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Respiratory muscle function in patients with 
asbestos-related pleural disease 
N. AL JARAD, M. P. CARROLL*, C. LAROCHE*, N. POULAKIS, J. MOXHAM*, M. GREEN* AND 
R. M. RUDDY 
The London Chest Hospital, Bonner Road, London E2 9JX and *The Royal Brompton National Heart and 
Lung Hospital, Sydney Street, London S W3, U.K. 
The effect of asbestos-related pleural disease (ARPD) on the generation of maximum respiratory pressure was 
investigated in 11 male patients with ARPD mean age 57 years, range 45-74, and mean duration of asbestos 
exposure of 9.9 years, range 5-16. There were three smokers, seven ex-smokers and one non-smoker. 
Breathlessness ranged from grade l-3 on the MRC score. The extent of pleural disease was calculated using 
a score based on the IL0 score for pleural disease. Full respiratory function tests, global respiratory muscle 
strength and diaphragmatic strength were assessed. 
Respiratory muscle strength, including diaphragm strength, was normal. Recoil pressure was high or at the 
upper limit of normal in four patients and correlated with chest radiograph score for pleural disease (rx0.65, 
PCO.02). 
There was no difference in either global respiratory muscle or diaphragmatic strength between patients with 
and without involvement of one or both costophrenic angles or between patients with mild or severe 
breathlessness. 
We conclude that respiratory muscle strength is not importantly reduced in ARPD, and it is unlikely that 
weakness contributes to breathlessness in these patients. By contrast reduced chest wall compliance is likely to 
be an important factor in breathlessness in some cases. 
Introduction 
Asbestos related pleural disease may cause breath- 
lessness even in the absence of interstitial fibrosis or a 
marked change in respiratory function tests (1,2). 
Asbestos-related pleural disease (ARPD) may 
involve the visceral pleura, parietal pleura, diaphrag- 
matic pleura and the costophrenic angles. Cotes 
reported that respiratory function tests were 
particularly compromised in those patients with 
asbestos related pleural disease in whom one or both 
costophrenic angles were involved (3). 
Several studies have found correlations between 
the extent of pleural disease and respiratory function 
impairment, but no correlation has been demon- 
strated between pleural disease and breathlessness 
(4,5). Impaired function of the diaphragm and other 
respiratory muscles may cause breathlessness and it is 
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plausible that asbestos-related pleural disease could 
cause breathlessness by such mechanisms. The effects 
of asbestos-induced pleural disease on respiratory 
muscle strength and diaphragmatic function have not 
previously been investigated. 
In this study we test the hypothesis that benign 
diffuse asbestos- induced pleural disease involving 
the diaphragm and costophrenic angles may impair 
diaphragmatic function and/or respiratory muscle 
strength. 
Patients and Methods 
PATIENTS 
Eleven male patients with asbestos related pleural 
disease and plain chest radiograph profusion score of 
less than l/O (mean age 57, range 45-74 years) were 
investigated. They had sustained asbestos exposure 
for a mean of 9.9 years (range 5-16 years) through 
working in insulation product factories (five patients) 
dockyards (five patients) or the building trade (one 
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Involvement of co&phrenic angle (1) 
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Involvement of disphragmatic pleura (2) 
Fig. I The chest radiograph scoring system for pleural disease. Lung score=length score x width score+scores for 
diaphragmatic pleura and costophrenic angles. Total score=score of the left lung+score of the right lung. 
patient). They were three current smokers, seven 
ex-smokers and one non-smoker. High resolution 
computed tomography was performed in all but one 
patient who suffered from claustrophobia. Diffuse 
pleural thickening was present in all patients. Cir- 
cumscribed plaques were present in eight patients and 
pleural calcification was present in five patients. 
Pleural disease involving the diaphragm was present 
in all patients. Interstitial lung disease was not 
present in any patient. 
All patients suffered from breathlessness (grade l-3 
on the MRC scale) (6). None had orthopnoea and 
none had any other symptoms, clinical, radiological 
or electrocardiographic signs of cardiac diseases. 
RESPIRATORY FUNCTION TESTS 
Respiratory function tests including spirometry 
using a dry cylinder spirometer (PK Morgan), diffus- 
ing capacity for carbon monoxide using an Auto- 
Link transfer factor machine (PK Morgan) and total 
lung capacity and residual volume using a constant 
volume body plethysmograph attached to an IBM 
computer (PK Morgan) were performed. 
CHEST RADIOGRAPH SCORING SYSTEM 
The chest radiograph scoring system for pleural 
disease has previously been described ($7) based on 
the International Labour Office scale for pleural 
disease (8): The score of each lung is calculated by 
multiplying the pleural disease length score (see face 
on) by the maximum width score. Marks are added 
when the diaphragmatic pleura and the costophrenic 
angles are involved. The final score is the sum of the 
score for the two lungs (Fig. 1). 
RESPIRATORY MUSCLE ASSESSMENT 
Measurements were made in the seated position, 
Oesophageal pressure (Poes) and gastric pressure 
(P,,) were recorded with a balloon catheter system 
connected to Validyne differential pressure trans- 
ducer (Model MP 45-l % 150 cm H,O; Validyne 
Corp., Northridge, CA, U.S.A.). Each balloon (PK 
Morgan, Kent, U.K.) was 10 cm long and 3.5 cm in 
circumference. The oesophageal balloon was pos- 
itioned in the oesophagus and contained 0.5 ml of 
air (9). This balloon-catheter system was used to 
measure the maximum static recoil pressure of the 
lung at TLC. The gastric balloon was positioned 
65 cm from the nares to the balloon tip and 
contained 1.5 ml of air (10). Pdi was derived 
electronically according to the equation; 
Pdi=P,, - Poes 
using Pdi at resting end-inspiration (FRC) as zero 
reference point. 
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Table 1 Chest radiograph score, and respiratory muscle function tests* 
No 
X-ray Poes Pdi Pdi Pdi Recoil 
score Psmax Ptmax sniff TLC sniff Prmax pressure 
1 5 100 85 75 85 120 135 25 
2* 7 115 68 108 70 135 135 25 
3 9 140 65 75 40 100 25 20 
4 9 149 50 65 33 90 83 30 
5* 9 133 65 90 28 135 68 23 
6** 12 130 112 138 65 147 100 60 
I 14 140 50 100 58 100 60 38 
8* 14 155 70 80 50 105 75 40 
9* 15 70 20 75 27 70 45 28 
10** 19 185 135 140 45 145 130 40 
11* 21 70 55 135 60 130 150 55 
Mean 125 71 105 51 116 91 36 
SD 35 69 31 19 25 42 13 
Normal:mean 145 104 105 >25 148 108 20-40 
6”) 33 30 26 24 30 
*The unit for all measurements is: cm H,O. 
Patients with one (*) or both (**) costophrenic angles involved by pleural disease on the chest 
radiograph. 
Diaphragmatic function was assessed by measur- 
ing Pdi during the three voluntary manoeuvres: 
maximal inspiration to TLC (Pdi:TLC), maximal 
static inspiratory effort from residual volume, 
maintained for one second against a closed airway 
(Pdi:Prmax) (11) and maximal sniffs from functional 
residual capacity (Pdi:sniK) (12). All measurements 
were repeated with a rest pause of 10 s between each 
attempt until a reproducible value was obtained for 
each manoeuvre. For sniff Pdi, sharp maximal sniffs 
were performed through the nose at FRC without a 
nose clip or a mouthpiece. They were repeated with a 
rest pause of at least 10 s between each sniff until 
reproducible values of Pdi had been achieved, usually 
within six sniffs. A further 10 maximal sniffs were 
used and the highest recorded value of Pdi was used 
for analysis. Global expiratory muscle strength was 
assessed by measuring the maximum pressure gener- 
ated at the mouth during a maximum occluded 
expiratory effort sustained for 1 s from total lung 
capacity (Pnmax) using a mouth piece and a nose clip 
(13). Global inspiratory muscle strength was assessed 
by measuring the maximum pressure generated at the 
mouth during a maximum occluded inspiratory effort 
sustained for 1 s from residual volume (Prmax) (13). 
Global inspiratory muscle strength was also 
assessed by measuring the maximum oesophageal 
pressure generated during a maximum inspiratory 
sniff from FRC, seated without a nose clip (Poes: 
sniff) using a balloon-catheter system to measure 
Poes (14). Vital capacity was recorded in the seated 
and supine postures using an Ohio 840 spirometer, 
and the supine fall in VC was calculated as the 
absolute fall taken as a percentage of VC in the 
seated position. 
STATISTICAL ANALYSIS 
The maximum mouth pressure values were com- 
pared with the normal range of Wilson et al. (13) 
and sniff oesophageal and sniff transdiaphragmatic 
pressures were compared with normal values of 
Miller, Moxham and Green (12). 
Comparisons between global respiratory muscle 
function in patients with mild breathlessness (grades 
1 and 2) and severe breathlessness (grade 3) and 
between patients with and without involvement of 
costophrenic angles were performed using the Mann- 
Whitney U-test. Correlations between the chest 
radiograph score and respiratory muscle function 
were performed using Spearman’s rank test. 
Results 
Patients in general had a restrictive ventilatory 
defect (mean ratio of forced expiratory volume in 
the first second (FEV,) to forced vital capacity 
(FVC) [(FEVrIFVC ratio)] 96% and mean total lung 
capacity (TLC) 86% of their predicted values) with 
preserved or increased KC0 (mean 110% of predicted 
value). 
Maximum static expiratory pressure (Pamax) 
ranged from 70-155 cm H,O (mean 125 cm H,O; 
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Fig. 2 Values of (a) global respiratory muscle strength measurements and (b) transdiaphragmatic pressures. Pamax: 
maximum expiratory mouth pressure, Prmax: maximum inspiratory mouth pressure, Poes sniff: Oesophageal pressure 
during amaximum inspiratory sniff, Pdi TLC: Transdiaphragmatic pressure at maximum inspiration [total lung capacity 
(TLC)]. Pdi sniff transdiaphragmatic pressure at maximum sniffs from functional residual capacity. Pdi Ptmax: maximum 
transdiaphragmatic pressure at residual volume, maintained for one second against close airways. (For further details see 
the method section). The horizontal lines are the upper and lower limits of normal. 
normal >80cm H,O), and was abnormally low in 
two patients. Maximum inspiratory mouth pressures 
were also recorded in one patient. Oesophageal sniff 
pressure was normal in all 11 patients. Maximum 
transdiaphragmatic pressure during a sniff (Pdi sniff) 
ranged between 70-147 cm H,O, mean 116, normal 
>lOO cm H,O. These results were below the lower 
limit of normal in two patients and at the lower limit 
of normal in two further patients. The relative con- 
tribution of oesophageal and gastric pressures were 
normal. Results of global respiratory muscle function 
and trans-diaphragmatic pressures are illustrated in 
Table 1 and Fig. 2. 
Mean maximum elastic recoil pressure was 36 cm 
H,O, (range 20-60) normal 20-40 cm H,O. It was 
high in two and at the upper limit of normal in a 
further two patients. The maximum elastic recoil 
pressure correlated with the chest radiograph score; 
rz0.65, PcO.02 (Spearman’s rank test) (Fig. 3). 
There was no significant difference between VC in 
the supine and prone positions. There was a negative 
correlation between chest radiographic score and 
vital capacity (r= - 0.90, P<O.O05), (Fig. 4). 
There were no differences in chest radiograph 
scores, lung function tests, global respiratory 
muscle tests or diaphragmatic strength tests between 
patients who had mild degrees of breathlessness (1,2) 
and patients who had moderate to severe breath- 
lessness (3) on the MRC scale (Mann-Whitney 
U-test). 
There were no differences in any of the global 
respiratory muscle or transdiaphragmatic pressure 
measurements between patients with and without 
involvement of one or both costophrenic angles by 
pleural disease on the chest radiograph (Mann- 
Whitney U-test). 
Discussion 
Breathlessness has been reported in patients with 
asbestos related pleural disease in several studies 
(1,4,5,15-17) but the correlation with the extent of 
pleural disease is poor. 
Normal ventilation is crucially dependent on the 
capacity of the respiratory muscles, particularly those 
sub-serving inspiration, to -generate adequate pres- 
sures. Respiratory muscle weakness is an important 
factor in the breathlessness and ventilatory failure of 
many patients with neuro-muscular diseases affecting 
the respiratory muscle and chest wall. We hypoth- 
esized that extensive pleural disease in patients with 
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Fig. 3 The chest radiograph score for pleural disease 
(X-ray score) correlated with elastic recoil pressure (rz0.65, 
P40.02). 
ARPD may importantly impair the pressure generat- 
ing capacity of the respiratory muscles, particularly 
the diaphragm. 
In general the capacity of patients with ARPD to 
generate maximum inspiratory pressures was well 
preserved. Conventionally global inspiratory muscle 
strength is measured by recording Prmax, and most 
investigators have documented efforts from residual 
volume ~ prior to maximal inspiratory efforts 
patients find it most appropriate to breathe fully out 
to residual volume. Only one patient had a low 
fimax result (patient number 9). In this patient the 
value was so low that the ability of the patient to 
perform the test properly must be questioned. Many 
patients find maximum static manoeuvres difficult 
and perform better when asked to undertake maxi- 
mum sniff manoeuvres. Patients find it most easy to 
sniff from FRC position and available normal data 
relates to sniff Pdi from FRC. Patient number 9 had 
normal sniff oesophageal pressure thereby excluding 
global inspiratory muscle weakness. Thus none of the 
11 patients had any evidence of global inspiratory 
muscle weakness. 
Transdiaphragmatic pressure recorded at total 
lung capacity is a relatively insensitive test of dia- 
phragm strength, and although normal in all of the 
patients it is possible that mild to moderate dia- 
phragm weakness could have been missed by this 
test. Many investigators have assessed diaphragm 
strength from a maximum static inspiratory 
manoeuvre- Pdi-Prmax, and in the present study two 
patients could be judged to be weak by this test 
(patients 3 and 9). However, sniff Pdi is a more easily 
performed manoeuvre with higher mean value and a 
narrower normal range. As judged by sniff Pdi only 
one patient (patient number 9) could be deemed to 
l_..,. 
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Fig. 4 The chest radiograph score for pleural disease 
(X-ray score) inversely correlated with vital capacity 
(r= - 0.90, P<O.O05). 
have diaphragm weakness and only marginally so 
(sniff Pdi 70 cm of water). 
Maximum expiratory pressures were well main- 
tained in this group of patients with marginally low 
values in just two patients (patients 9 and 11). The 
difficulty experienced by patient number 9 with 
static inspiratory manoeuvres suggests that the 
value for this patient for static expiratory pressure 
could have been reduced because of difficulties with 
the test. The marginal expiratory muscle weakness 
in patient number 11, is in contrast to his greater 
than average inspiratory muscle strength. There is 
no single perfect test of respiratory muscle strength 
that provide a ‘gold standard’. Laboratories that 
routinely investigate respiratory muscle strength, 
therefore apply a battery of tests. The respiratory 
muscle test results in these 11 patients with ARPD 
demonstrate that strength is normal in most 
patients and possibly mildly reduced in just two 
cases. It is therefore unlikely that breathlessness 
experienced by these patients could be explained, 
even in part, by respiratory muscle weakness. None 
of the patients in this study had any orthopnoea 
which is the main symptom in the presence of 
severely compromised diaphragmatic function but 
they all had breathlessness on mild exercise. Pleural 
disease had an effect on lung function as illustrated 
by a decrease of TLC and the apparently normal 
value of RV which probably resulted from the sum 
of the restrictive defect of pleural disease and the 
obstructive defect of the smoking induced chronic 
airflow limitation. 
In the current study, respiratory muscle function 
tests did not differ in patients with and without 
involvement of the costophrenic angles, a factor 
which has been suggested to correlate with 
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impairment of lung function (3). Recoil pressure 
was, however, increased in two and was at the upper 
limit of normal in a further two patients and it 
correlated with the chest radiograph score for 
ARPD. 
Breathlessness in patients with asbestos related 
pleural disease may be multifactorial and could relate 
to the increase of recoil pressure, smoking related 
lung disease and possibly mood. Another possible 
factor may be that the diffuse thickening which 
involves the visceral pleura could stimulate receptors 
in the alveolar walls adjacent to the pleural surface. 
It is concluded that in ARPD, global inspiratory 
muscle strength is well preserved and weakness is 
unlikely to contribute to breathlessness. Recoil press- 
ure is mildly increased and this measurement shows a 
weak correlation with the extent of pleural disease. 
Reduced compliance may be a contributory factor in 
the breathlessness of some patients. 
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